Lundbeck to highlight mechanistic insights on bexicaserin's dual mode of action at the European Epilepsy Congress

Summary

Lundbeck will present preclinical data on bexicaserin's dual mode of action at the European Epilepsy Congress, showing the drug's inhibitory and excitatory effects on neuronal activity with potential antiseizure activity across focal, generalized motor, and absence seizures.